© Benchmark Genetics
Geir Olav has been with the Benchmark Group for six years, playing an important role in the growth of its aquaculture genetics business. He served as head of the genetics business area in Benchmark Holdings before being appointed CEO of Benchmark Genetics on 1 April 2025, following the company’s transition to independent ownership under Novo Holdings.
Novo Holdings has initiated the search for a new CEO. In the meantime, Aleks Engel, a partner at Novo Holdings, will be appointed interim CEO, supported by a dedicated team from the firm.
“It has been a privilege to lead Benchmark Genetics through an exciting phase of growth and transition. I believe strongly in the company's future and the potential of its partnership with Novo Holdings,” said Geir Olav Melingen in a press release. “This decision reflects a personal career step, and I remain fully committed to ensuring a seamless transition in the period ahead.”
Under Melingen’s leadership, Benchmark Genetics has strengthened its position as a global leader in aquaculture genetics, delivering solutions for salmon, shrimp, and genetic programmes worldwide.
“Geir Olav has played a central role in building Benchmark Genetics into a strong and focused organisation with a clear strategic direction,” said Aleks Engel, interim CEO. “On behalf of Novo Holdings and the board, I want to thank him for his leadership and dedication.”
© Benchmark Genetics
